Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $193.47 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $155.92 | 3 | $0 (2017) |
| ABBVIE INC. | $24.18 | 1 | $0 (2022) |
| Lilly USA, LLC | $13.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $24.18 | 1 | ABBVIE INC. ($24.18) |
| 2017 | $169.29 | 4 | Allergan Inc. ($155.92) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 147 | 267 | $77,508 | $18,534 |
| 2022 | 6 | 200 | 488 | $104,419 | $28,469 |
| 2021 | 7 | 150 | 266 | $125,835 | $17,147 |
| 2020 | 4 | 109 | 231 | $99,729 | $19,236 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 150 | $28,933 | $9,249 | 32.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $14,083 | $3,519 | 25.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 26 | $11,139 | $2,614 | 23.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 24 | 38 | $20,214 | $2,112 | 10.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 27 | $3,139 | $1,039 | 33.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 208 | $35,000 | $11,647 | 33.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 35 | 95 | $25,732 | $5,427 | 21.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 40 | $14,467 | $4,231 | 29.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 46 | 114 | $12,782 | $3,443 | 26.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $11,074 | $2,634 | 23.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $5,364 | $1,087 | 20.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 67 | $29,784 | $4,724 | 15.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 29 | 65 | $42,714 | $3,268 | 7.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 41 | $17,835 | $2,828 | 15.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 16 | $12,620 | $2,289 | 18.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 36 | $10,120 | $2,008 | 19.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 13 | $8,060 | $1,194 | 14.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 28 | $4,702 | $836.83 | 17.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 117 | $46,568 | $9,456 | 20.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 33 | 33 | $24,905 | $5,182 | 20.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 54 | $15,932 | $3,073 | 19.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 12 | 27 | $12,324 | $1,524 | 12.4% |
About Dr. Hang Vu, MD
Dr. Hang Vu, MD is a Hospitalist healthcare provider based in Bar Harbor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730140476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hang Vu, MD has received a total of $193.47 in payments from pharmaceutical and medical device companies, with $24.18 received in 2022. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($193.47).
As a Medicare-enrolled provider, Vu has provided services to 606 Medicare beneficiaries, totaling 1,252 services with total Medicare billing of $83,386. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Nephrology, Hospitalist
- Location Bar Harbor, ME
- Active Since 03/31/2006
- Last Updated 10/23/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1730140476
Products in Payments
- NAMZARIC (Drug) $125.00
- VRAYLAR (Drug) $30.92
- VENCLEXTA (Drug) $24.18
- TRULICITY (Drug) $13.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.